{"denoms":[{"counts":[{"groupId":"BG000","value":"357"},{"groupId":"BG001","value":"355"},{"groupId":"BG002","value":"357"},{"groupId":"BG003","value":"1069"}],"units":"Participants"}],"groups":[{"description":"Participants received lenvatinib 18 milligrams (mg) administered orally, once daily in each 21-day cycle, plus everolimus 5 mg administered orally, once daily in each 21-day cycle until participant had disease progression, development of unacceptable toxicity, participant request, withdrawal of consent.","id":"BG000","title":"Lenvatinib 18 mg Plus Everolimus 5 mg"},{"description":"Participants received lenvatinib 20 mg administered orally, once daily in each 21-day cycle, plus pembrolizumab 200 mg administered intravenously, every 3 weeks in each 21-day cycle until participant had disease progression, development of unacceptable toxicity, participant request, withdrawal of consent, completion of 35 treatments (approximately 2 years) with pembrolizumab, or sponsor termination of the study.","id":"BG001","title":"Lenvatinib 20 mg Plus Pembrolizumab 200 mg"},{"description":"Participants received sunitinib 50 mg administered orally, once daily, on a schedule of 4 weeks on treatment followed by 2 weeks off treatment until participant had disease progression, development of unacceptable toxicity, participant request, withdrawal of consent.","id":"BG002","title":"Sunitinib 50 mg"},{"description":"Total of all reporting groups","id":"BG003","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"10.86","value":"61.9"},{"groupId":"BG001","spread":"10.23","value":"62.3"},{"groupId":"BG002","spread":"9.96","value":"60.8"},{"groupId":"BG003","spread":"10.36","value":"61.7"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"91"},{"groupId":"BG001","value":"100"},{"groupId":"BG002","value":"82"},{"groupId":"BG003","value":"273"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"266"},{"groupId":"BG001","value":"255"},{"groupId":"BG002","value":"275"},{"groupId":"BG003","value":"796"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"23"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"20"},{"groupId":"BG003","value":"55"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"328"},{"groupId":"BG001","value":"339"},{"groupId":"BG002","value":"334"},{"groupId":"BG003","value":"1001"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"6"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"13"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"254"},{"groupId":"BG001","value":"263"},{"groupId":"BG002","value":"270"},{"groupId":"BG003","value":"787"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"6"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"77"},{"groupId":"BG001","value":"81"},{"groupId":"BG002","value":"67"},{"groupId":"BG003","value":"225"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"1"}],"title":"American Indian or Alaskan Native"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"1"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"7"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"7"},{"groupId":"BG003","value":"18"}],"title":"Other"},{"measurements":[{"groupId":"BG000","value":"16"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"10"},{"groupId":"BG003","value":"31"}],"title":"Missing"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"}],"populationDescription":"The full analysis set (FAS) included all randomized participants regardless of the treatment actually received."}